Published in Women's Health Weekly, December 22nd, 2005
Conclusive evidence has demonstrated that fulvestrant, which is administered as a once-monthly intra-muscular (IM) injection, is at least as effective as the gold-standard aromatase inhibitor (AI) Arimidex (anastrozole) in this setting, as well as being better tolerated....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly